Surgery or radiotherapy for early-stage cancer study (SORT) target trial protocol: stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for early-stage non-small cell lung cancer (NSCLC)
Introduction Randomised controlled trials have aimed to assess the effectiveness of stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for individuals diagnosed with early-stage non-small cell lung cancer (NSCLC) but have failed to recruit sufficient numbers of...
Saved in:
| Main Authors: | John Edwards, Corinne Faivre-Finn, Ellen Nolte, Bernard Rachet, Ajay Aggarwal, Ravinder Vohra, Richard Grieve, Andrew Hutchings, Ananya Choudhury, Stephen O’neill, Yuki Alencar, Paul Charlton, Dave Chuter, Eva Kagenaar, David G. Lugo-Palacios, Jo Cresswell, Katya Gravenhorst, Daniel Mongiardi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/7/e103038.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors
by: Nicolas Giraud, et al.
Published: (2025-09-01) -
Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer
by: Yun Bai, et al.
Published: (2025-01-01) -
Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer
by: Aisling Barry, et al.
Published: (2018-01-01) -
Assessment of Tumor Infiltrating Lymphocytes in Predicting Stereotactic Ablative Radiotherapy (SABR) Response in Unresectable Breast Cancer
by: Mateusz Bielecki, et al.
Published: (2025-04-01) -
Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC
by: Chao Liu, et al.
Published: (2025-02-01)